Severe Hemophilia A Recruiting Phase 2 Trials for Antihemophilic factor human (DB13192)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05265286A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionTreatment